{"schema_version": 1, "id": "yuba-city-ca-msa/life-sciences/2026-09", "product": "Labor Market Pulse", "metro": {"geography_id": 458, "label": "Yuba City, CA MSA", "slug": "yuba-city-ca-msa"}, "focus_area": {"key": "life_sciences", "slug": "life-sciences", "label": "Life Sciences"}, "period": "2026-09", "public_after": "2026-09-01", "frozen_at": "2026-10-09T13:25:23.673689+00:00", "headline": "Yuba City's CRA pay gap signals a thin talent pool, not savings.", "headline_summary": "Yuba City advertised Clinical Research Associate pay sits at $67,930 against a $90,956 national median, even as county unemployment above 7% outpaces the 5.1% statewide rate \u2014 a combination suggesting labor surplus without matching specialized talent supply.", "key_indicators": [{"label": "Yuba County unemployment", "value": "6.7%", "context": "vs 5.1% California, 4.1% national (Aug 2026)"}, {"label": "Sutter County unemployment", "value": "7.4%", "context": "Highest in region, vs 5.1% statewide"}, {"label": "CRA advertised pay, metro vs national", "value": "$67,930 vs $90,956", "context": "Metro down significant, national up significant"}, {"label": "CA life sciences avg. salary", "value": "$192,179", "context": "Across 406,000+ CA life sciences workers"}], "takeaways": [{"headline": "CRA pay gap here is a staffing warning, not a bargain.", "body": "Advertised Clinical Research Associate pay in Yuba City runs nearly 25% below the national median, which in a metro without a life sciences cluster more likely reflects a shallow applicant pool than genuine cost savings. Roles sited or sourced locally risk longer vacancy durations and lower-credentialed applicant flow."}, {"headline": "Metro unemployment running hot doesn't mean skilled talent is available.", "body": "Yuba and Sutter counties post unemployment above 7%, well ahead of the 5.1% state and 4.1% national rates, but the surplus concentrates in agriculture and retail, not laboratory, clinical, or regulatory occupations. Headcount plans assuming easy local sourcing for credentialed life sciences roles should be reconsidered in favor of regional recruiting."}, {"headline": "BioMarin and Amgen cuts widen the statewide talent pool life sciences employers can tap.", "body": "BioMarin's planned 117-role reduction at its Novato site and Amgen's July layoffs add experienced regulatory, quality, and manufacturing talent to the broader Northern California market. Valley-based or remote-friendly employers may find this consolidation activity creates near-term access to credentialed candidates otherwise unreachable from a thin local base."}, {"headline": "Build-vs-outsource math tilts further toward CDMO reliance in secondary metros.", "body": "With in-state manufacturing capacity consolidating around BioMarin's 'smaller, more focused' footprint and GLP-1-driven demand already straining specialized manufacturing and quality talent nationally, locating new production or quality functions in a non-cluster metro like Yuba City raises execution risk. Current conditions suggest evaluating CDMO partnerships before committing to local headcount builds for manufacturing-adjacent roles."}], "local_conditions": "Yuba City's dual-county unemployment rate \u2014 6.7% in Yuba County and 7.4% in Sutter County as of August \u2014 remains well above both the state's 5.1% and national 4.1%, reflecting the metro's agricultural labor base rather than any life sciences employment presence. With healthcare and social assistance already the metro's largest sector at 8,503 workers and no biotech, pharma, or device manufacturing cluster of scale, life sciences hiring here functions almost entirely as an extension of Sacramento-area and Bay Area labor markets rather than a standalone talent pool.", "implications": "Clinical Research Associate advertised pay in the metro sits at $67,930 against a $90,956 national median \u2014 a gap wide enough to signal that any CRA or clinical-adjacent roles based in Yuba City are being priced against a thin local labor pool rather than the specialized national clinical talent market, raising real risk of candidate mismatch or prolonged vacancy for credentialed roles. Organizations weighing a Sacramento-Valley site for clinical operations, quality, or regulatory functions should treat local advertised rates as a signal of recruiting difficulty, not a cost advantage, and model remote or hybrid structures that let Sacramento- or Bay Area-based specialists anchor compensation instead of the metro median. Consider evaluating whether any clinical or regulatory-adjacent roles currently benchmarked to Yuba City-area pay should instead reference regional California life sciences rates to avoid under-pricing scarce talent.", "looking_ahead": [{"category": "Worth watching", "body": "September and October WARN filings from BioMarin, Amgen, and other California pharma employers may release regulatory, quality, and clinical talent into the broader Sacramento-Valley commuter radius. Track whether any of that talent surfaces in Yuba City-area applicant pools for hybrid or remote roles."}, {"category": "Emerging pressure point", "body": "Metro unemployment running roughly two points above the state average signals continued labor force softness; watch whether this draws non-life-sciences job seekers into healthcare support roles that could eventually feed clinical operations pipelines."}, {"category": "Early indicator", "body": "California's $23.9 million life sciences workforce investment in LA County signals where state dollars are building talent pipelines \u2014 none currently directed at the Sacramento Valley. Monitor whether future state workforce funding rounds extend regional eligibility."}, {"category": "Potential inflection point", "body": "National CRA advertised pay rose while Yuba City's fell \u2014 a divergence worth re-checking next month to confirm whether it reflects a genuine local posting pattern or a thin, volatile sample size given the metro's small life sciences employer base."}], "roles": [{"role": "Research Scientist", "data_scope": "state_rollup", "metro_p25": 115348.0, "metro_p50": 151191.0, "metro_p75": 162812.5, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 131354.0, "national_trend_direction": "up", "national_trend_magnitude": "significant"}, {"role": "Clinical Research Associate", "data_scope": "metro", "metro_p25": 67930.0, "metro_p50": 67930.0, "metro_p75": 67930.0, "metro_trend_direction": "down", "metro_trend_magnitude": "significant", "national_p50": 90955.8, "national_trend_direction": "up", "national_trend_magnitude": "significant"}, {"role": "Lab Technician", "data_scope": "state_rollup", "metro_p25": 44720.0, "metro_p50": 52416.0, "metro_p75": 57803.0, "metro_trend_direction": "down", "metro_trend_magnitude": "moderate", "national_p50": 47402.2, "national_trend_direction": "down", "national_trend_magnitude": "moderate"}, {"role": "Regulatory Affairs Specialist", "data_scope": "state_rollup", "metro_p25": 79748.25, "metro_p50": 109176.0, "metro_p75": 127559.0, "metro_trend_direction": "stable", "metro_trend_magnitude": "stable", "national_p50": 104000.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Clinical Data Manager", "data_scope": "state_rollup", "metro_p25": 108779.75, "metro_p50": 139084.0, "metro_p75": 152500.0, "metro_trend_direction": "down", "metro_trend_magnitude": "moderate", "national_p50": 123031.0, "national_trend_direction": "down", "national_trend_magnitude": "moderate"}, {"role": "Biostatistician", "data_scope": "state_rollup", "metro_p25": 112800.0, "metro_p50": 136074.0, "metro_p75": 171066.0, "metro_trend_direction": "up", "metro_trend_magnitude": "moderate", "national_p50": 133322.0, "national_trend_direction": "up", "national_trend_magnitude": "moderate"}, {"role": "Validation Engineer", "data_scope": "state_rollup", "metro_p25": 97201.5, "metro_p50": 114857.0, "metro_p75": 122444.0, "metro_trend_direction": "down", "metro_trend_magnitude": "moderate", "national_p50": 108377.0, "national_trend_direction": "up", "national_trend_magnitude": "moderate"}], "industry_snapshot": [], "citations": [], "methodology": "Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay.", "edition_label": "October 2026", "files": {"html": "yuba-city-ca-msa/life-sciences/2026-09.html", "pdf": "yuba-city-ca-msa/life-sciences/2026-09.pdf"}, "published_at": "2026-10-09T14:38:19.512628+00:00", "report_html_url": "https://reports.wagescape.com/archive/v1/editions/yuba-city-ca-msa/life-sciences/2026-09.html", "report_pdf_url": "https://reports.wagescape.com/archive/v1/editions/yuba-city-ca-msa/life-sciences/2026-09.pdf"}